期刊文献+

急性脑梗死患者中血清胱抑素C及凝血功能检验的应用分析 被引量:1

Application Analysis of Serum Cystatin C and Coagulation Function Test in Patients with Acute Cerebral Infarction
下载PDF
导出
摘要 目的探讨急性脑梗死患者中血清胱抑素C(CysC)及凝血功能检验的应用。方法抽取2017年1月至2019年1月45例急性脑梗死患者作为观察组,抽取同期体检的45名健康者作为对照组,均实施CysC及凝血功能检验,对比检查结果。结果观察组CysC、血浆纤维蛋白(Fg)均高于对照组,且血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)均短于对照组(P<0.05);进展型脑梗死、完全型脑梗死、对照组3组间CysC、Fg、PT、APTT数据比较差异有统计学意义(P<0.05)。结论急性脑梗死患者中CysC及凝血功能检验的应用价值显著,可提升检出率,同时还可对患者病情严重程度进行评估。 Objective To investigate the application of serum cystatin C(CysC)and coagulation function test in patients with acute cerebral infarction.Methods Forty-five patients with acute cerebral infarction from January 2017 to January 2019 were selected as the observation group,and 45 healthy patients were selected as the control group during the same period of physical examination.All patients were tested for CysC and coagulation function,and the results were compared.Results CysC and plasma fibrin(Fg)were higher in the observation group than in the control group,and plasma prothrombin time(PT)and activated part of thrombin time(APTT)in the observation group was lower than that of the control group(P<0.05).There were significant differences in CysC,Fg,PT and APTT between progressive cerebral infarction,complete cerebral infarction and control group(P<0.05).Conclusion The application value of CysC and coagulation function test in patients with acute cerebral infarction is significant,which can improve the detection rate,and also can evaluate the severity of patients'condition.
作者 张玉婷 ZHANG Yuting(Department of Clinical Laboratory,Affiliated Central Hospital of Shenyang Medical College,Shenyang 110005,China)
出处 《中国医药指南》 2022年第2期124-126,共3页 Guide of China Medicine
关键词 急性脑梗死 血清胱抑素C 凝血功能检验 Acute cerebral infarction Serum cystatin C Coagulation function test
  • 相关文献

参考文献9

二级参考文献77

  • 1李继锋,孙圣刚,王舟,蔡高梅,顾克金,李耀群.脑动脉狭窄患者认知功能障碍的研究[J].中国行为医学科学,2006,15(8):701-703. 被引量:5
  • 2陈士华.血清CysC检测在糖尿病早期肾损害中的应用价值[J].浙江中西医结合杂志,2007,17(9):548-548. 被引量:5
  • 3Chew JS,Saleem M,Florkowski CM,et al.Cystatin C-a paradigm of evidence based laboratory medicine[J].Clin Biochem Rev,2008,29:47-62.
  • 4Jovanovic D,Krstivojevic P,Obradovic I,et al.Serum cystatin C and beta2-microglobulin as markers of glomerular filtrationrate[J].Ren Fail,2003,25(1):123-125.
  • 5Arpegard J,Ostergren J,de Faire U,et al.Cystatin C-amarker of peripheral atherosclerotic disease[J].Athero-sclerosis,2008,199 (2):397-401.
  • 6Bengtsson E,To F,Grubb A,et al.Absence of the protease Inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apo E-deficient mice[J].Atherosclerosis,2005,1 80:45-53.
  • 7Tsai HT,Wang PH,Tee YT,et al.Imbalanced serum concentration between cathepsin B and evstatin C in patients with pelvic inflammatory disease[J].Fertil Steril,2009,91:549-555.
  • 8王维治.主编.神经病学[M].第5版.北京:人民卫生出版社,2004.168.
  • 9Hennerici M G, Kay R, Bogousslavsky J, et al. Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Anerod Trial : a randomised controlled trial [ J ]. Lancet, 2006,368 ( 9550 ) : 1871-1878.
  • 10Hansen M K,Jensen M K,Andersen C. Uncontrollable bleeding in a patient with head trauma treated with blood component therapy guided by thromboelastography [ J ]. Ugeskr Laeger, 2002 ( 168 ) , 3535 -3536.

共引文献172

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部